Sign in Pull a receipt

OKUR

OnKure Therapeutics, Inc.

Healthcare · Biotechnology

$69.66 sample

-1.05 (-1.48%) 1D

Market cap

$125.2B

Price as of

2026-10-29

Latest filing

8-K · 2026-09-22

Alerts

8

Price$69.66 +12.92% 3M daily closessample

72.7961.69

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 26INSInsider sell: EVP, Operations
Oct 21INSInsider sell: Chief Financial Officer
Oct 13INSInsider sell: Chief Executive Officer
Oct 06INSInsider sell: 10% owner
Sep 29INSInsider buy: General Counsel
Sep 22SECDEF 14A filed
Sep 11INSInsider sell: 10% owner
Sep 04SEC8-K filed: material event

Sign up to see the real OKUR record →

Company facts

SEC EDGAR registration

Name: OnKure Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -55sample, -100 to +100
Reporting currency: USD

Who is positioning in OKUR

sample

Insiders: 31 insider transactions over 90 days, net selling, $334.8M
Congress: No member trades over 90 days
Institutions · 13F: 41 funds hold $1.1B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$5.6B +17.7% y/y

Q4 2024Q3 2026

Inventory$3.3B +15.7% y/y

Q4 2024Q3 2026

Accounts receivable$2.5B +5.4% y/y

Q4 2024Q3 2026

Total debt$6.4B +13.1% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $54.6B -9.9% 3M
Sample peer B: $43.6B +0.3% 3M
Sample peer C: $101.5B +12.1% 3M
Sample peer D: $38.7B +9.6% 3M
Sample peer E: $36.4B +13.1% 3M